NSWRC(SH:600165)2016-04-29 16:00Financial Performance - Operating revenue surged by 284.76% to CNY 639,301,901.39 year-on-year[6] - Net profit attributable to shareholders was a loss of CNY 20,106,206.17, an improvement from a loss of CNY 32,307,506.76 in the same period last year[6] - Operating revenue increased to $639.30 million, up 284.76% from $166.15 million in the same period last year[13] - The net loss for Q1 2016 was ¥19,158,310.66, compared to a net loss of ¥32,299,735.42 in Q1 2015, showing an improvement of approximately 40.6%[34] - The company reported an operating profit of -¥18,669,099.18 for Q1 2016, an improvement from -¥34,910,419.21 in Q1 2015[34] Cash Flow - Cash flow from operating activities showed a negative net amount of CNY 32,690,687.06, a decline of 121.40% compared to the previous year[6] - Net cash flow from operating activities decreased to -$32.69 million, a decline of 121.40% compared to $152.78 million in the previous year[15] - The cash flow from operating activities shows a net outflow of -¥32,690,687.06, compared to a net inflow of ¥152,781,832.94 in the previous period[41] - Operating cash flow for Q1 2016 was negative at -29,214,579.96 RMB, a significant decrease from 137,716,240.88 RMB in the same period last year, reflecting a decline of approximately 121%[44] - The company’s cash flow from investment activities was negative at -2,494,545.79 RMB, compared to -231,823,610.43 RMB in the same period last year, showing an improvement of approximately 99%[44] Assets and Liabilities - Total assets increased by 5.20% to CNY 4,126,798,544.70 compared to the end of the previous year[6] - The company's current assets totaled CNY 1,414,239,843.33, up from CNY 1,207,447,820.62 at the start of the year, reflecting a growth of approximately 17.1%[24] - The total liabilities reached CNY 3,117,628,630.24, compared to CNY 2,890,438,452.86 at the beginning of the year, indicating an increase of approximately 7.9%[26] - The company's short-term borrowings rose to CNY 1,099,780,000.00 from CNY 914,760,000.00, marking an increase of about 20.2%[25] - The company's total liabilities increased to ¥2,606,998,816.94 from ¥2,507,302,492.33, marking a rise of approximately 4.0%[29] Shareholder Information - The number of shareholders reached 34,030, with the top ten shareholders holding a combined 78.12% of shares[9] - The company has committed to not engaging in competitive business activities with its main operations and ensuring the protection of minority shareholders' interests[19] Operational Costs - Operating costs rose to $607.27 million, reflecting a 295.36% increase from $153.60 million year-over-year[13] - Sales expenses increased to $20.98 million, a rise of 56.26% from $13.42 million year-over-year, primarily due to the consolidation of Boya Stem Cell Technology Co., Ltd.[14] - Management expenses rose to $16.98 million, an 18.00% increase from $14.39 million, also attributed to the consolidation of Boya Stem Cell Technology Co., Ltd.[14] Other Financial Metrics - The weighted average return on net assets was -0.021%, an improvement from -3.571% in the previous year[6] - The company recorded a total of CNY 414,408.44 in non-recurring gains and losses during the reporting period[7] - The company has not indicated any significant changes in its net profit forecast for the year compared to the previous year[21] - Basic and diluted earnings per share for Q1 2016 were both -¥0.029, compared to -¥0.118 in the same quarter last year, indicating a reduction in loss per share[35]